Collaboration promotes sustainable pharmaceutical packaging
Four Japanese pharmaceutical companies agree to collaborate on promoting more sustainable pharmaceutical packaging.
List view / Grid view
Four Japanese pharmaceutical companies agree to collaborate on promoting more sustainable pharmaceutical packaging.
Japan has procurement deals with half of the companies leading the COVID-19 vaccine development race, according to GlobalData.
In an $882 million deal, Evox and Takeda will partner to develop and manufacture treatments and drug delivery systems for rare diseases.
Rising temperatures will likely accelerate the spread of vector-borne diseases, resulting in an increased demand for vaccines. European Pharmaceutical Review investigates a Morgan Stanley report on the pharmaceutical beneficiaries of climate change.